Anti-infectives | Company and Drugs | Global | 2020

launch Related Market Assessment Reports

• Hepatitis B Virus – Geographic Focus: China – Hepatitis B Virus – China In-Depth – China

  July 2023

  The prevalence of HBV is a major public health concern in China. Patients chronically infected with HBV are at high risk of developing hepatic cirrhosis and hepatocellular carcinoma. The majority…

• Heart Failure – Geographic Focus: China – Heart Failure | China In-Depth | China

  December 2022

  Heart failure presents a major public health burden in China. With a rapidly rising urban population and a growing trend of unhealthy lifestyle, heart failure is expected to affect a sizeable…

• Neuromyelitis Optica Spectrum Disorder (NMOSD) – Epidemiology – Mature Markets

  November 2022

  Clarivate Epidemiology’s coverage of neuromyelitis optica spectrum disorder (NMOSD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the…

• Idiopathic Pulmonary Fibrosis – Epidemiology – Emerging Markets

  June 2022

  Clarivate Epidemiology’s coverage of idiopathic pulmonary fibrosis (IPF) comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (China, India,…

• Biosimilars | Target Product Profile Simulator | Oncology | 2020

  December 2020

  Abstract here